Skip to content

Investment Purchases at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$144M-42.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$819.5M+200%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$15.01M-90.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$58.3M+692%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$30.37M-29.8%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$486.78M+316%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.45B+109%
Enterprise value$1.4B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: MapLight Therapeutics, Inc. ’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's investment purchases?
MapLight Therapeutics, Inc. (MPLT) reported investment purchases of $266.18M in Q4 2025.
How has MapLight Therapeutics, Inc. 's investment purchases changed year-over-year?
MapLight Therapeutics, Inc. 's investment purchases increased by 751.6% year-over-year, from $31.25M to $266.18M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.